Business Segments · Investment income
Reportable Segment — Investment income
Insmed Reportable Segment — Investment income decreased by 82.7% to $12.04M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 186.6%, from -$13.91M to $12.04M. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Investment income shows an upward trend with a 76.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026
How to read this metric
Higher income suggests a larger cash balance or a more favorable interest rate environment.
Detailed definition
This represents the interest and returns earned on the company's cash, cash equivalents, and marketable securities. It r...
Peer comparison
Standard financial metric for companies with significant cash reserves.
Metric ID:
insm_segment_reportable_segment_investment_incomeHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.77M | $2.77M | $2.77M | $2.77M | $10.53M | $10.53M | $10.53M | $10.53M | -$8.78M | -$10.29M | $16.98M | $55.39M | -$13.91M | -$13.23M | $18.29M | $69.50M | $12.04M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +280.2% | +0.0% | +0.0% | +0.0% | -183.4% | -17.1% | +265.1% | +226.2% | -125.1% | +4.9% | +238.3% | +280.0% | -82.7% |
| YoY Change | — | — | — | — | +280.2% | +280.2% | +280.2% | +280.2% | -183.4% | -197.6% | +61.2% | +425.9% | -58.3% | -28.6% | +7.7% | +25.5% | +186.6% |
Range-$13.91M – $69.50M
CAGR+44.4%
Avg YoY Growth+104.6%
Median YoY Growth+61.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Insmed's reportable segment — investment income?
- Insmed (INSM) reported reportable segment — investment income of $12.04M in Q1 2026.
- How has Insmed's reportable segment — investment income changed year-over-year?
- Insmed's reportable segment — investment income increased by 186.6% year-over-year, from -$13.91M to $12.04M.
- What is the long-term trend for Insmed's reportable segment — investment income?
- Over 3 years (2022 to 2025), Insmed's reportable segment — investment income has grown at a 76.2% compound annual growth rate (CAGR), from $11.08M to $60.66M.
- What does reportable segment — investment income mean?
- Income generated from the company's cash and investment holdings.